FRAAX
Price
$60.45
Change
+$0.64 (+1.07%)
Updated
Aug 6 closing price
Net Assets
4.72B
GFACX
Price
$71.52
Change
+$0.63 (+0.89%)
Updated
Aug 6 closing price
Net Assets
324.74B
Interact to see
Advertisement

FRAAX vs GFACX

Header iconFRAAX vs GFACX Comparison
Open Charts FRAAX vs GFACXBanner chart's image
Franklin Growth Opportunities Adv
Price$60.45
Change+$0.64 (+1.07%)
VolumeN/A
Net Assets4.72B
American Funds Growth Fund of Amer C
Price$71.52
Change+$0.63 (+0.89%)
VolumeN/A
Net Assets324.74B
FRAAX vs GFACX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FRAAX vs. GFACX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FRAAX is a Buy and GFACX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 325B vs. FRAAX (4.72B). FRAAX (0.00) and GFACX (0.00) have matching dividends . FRAAX was incepted earlier than GFACX: FRAAX (26 years) vs GFACX (24 years). GFACX (1.36) is less costly to investors than FRAAX (0.66). FRAAX is a more actively managed with annual turnover of: 27.59 vs. GFACX (25.00). GFACX has a lower initial minimum investment than FRAAX: GFACX (250) vs FRAAX (100000). GFACX annual gain was more profitable for investors over the last year : 18.41 vs. FRAAX (10.68). GFACX return over 5 years is better than : 33.13 vs. FRAAX (10.03).
FRAAXGFACXFRAAX / GFACX
Total Expense Ratio0.661.3649%
Annual Report Gross Expense Ratio0.661.3649%
Fund Existence26 years24 years-
Gain YTD6.17812.17151%
Front LoadN/AN/A-
Min. Initial Investment10000025040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets4.72B325B1%
Annual Yield % from dividends0.000.00-
Returns for 1 year10.6818.4158%
Returns for 3 years21.9939.6355%
Returns for 5 years10.0333.1330%
Returns for 10 years64.4967.8595%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SPRO2.260.14
+6.60%
Spero Therapeutics
UXIN3.830.11
+2.96%
Uxin Limited
CCRN13.100.26
+2.02%
Cross Country Healthcare
GBDC14.78-0.01
-0.07%
Golub Capital BDC
CRBG34.23-0.07
-0.20%
Corebridge Financial